Quazepam
Alternative Names: Doral; SCH 161; SCH 16134Latest Information Update: 03 Jan 2022
At a glance
- Originator Schering-Plough
- Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Insomnia; Sleep disorders
Most Recent Events
- 03 Jan 2022 Launched for Insomnia in USA (PO) (Galt Pharmaceuticals pipeline, January 2022)
- 22 Jan 2017 Cutis Health has been acquired by Galt Pharmaceuticals
- 14 Aug 2014 Questcor Pharmaceuticals has been acquired by Mallinckrodt plc